Sangamo: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Wednesday reported a loss of $60.3 million in its fourth quarter.

On a per-share basis, the Brisbane, California-based company said it had a loss of 34 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drug developer posted revenue of $2 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $9 million.

For the year, the company reported a loss of $257.8 million, or $1.48 per share. Revenue was reported as $176.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO

Advertisement

Recommended Stories